Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple -Negative Breast Cancer”

1,411 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,411 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT04032080
What this trial is testing

LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Baylor Research Institute 10
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Not applicableLooking for participantsNCT07073755
What this trial is testing

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Who this might be right for
Metastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital 200
Not applicableNot Yet RecruitingNCT07191405
What this trial is testing

Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors

Who this might be right for
ImmunotherapyChemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 156
Not applicableActive Not RecruitingNCT03165487
What this trial is testing

Comparison of the Breast Tumor Microenvironment

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast
Columbia University 14
Testing effectiveness (Phase 2)Study completedNCT02370238
What this trial is testing

Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 194
Testing effectiveness (Phase 2)WithdrawnNCT02338531
What this trial is testing

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

Who this might be right for
Breast Cancer
Jules Bordet Institute
Not applicableStudy completedNCT05750719
What this trial is testing

BRCA and NACT in TNBC Patients

Who this might be right for
Triple-Negative Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 136
Not applicableStudy completedNCT01461044
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 228
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Not applicableEnded earlyNCT03970967
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Who this might be right for
Breast CarcinomaMetastatic Breast CancerInvasive Breast Cancer+1 more
Alpha Tau Medical LTD. 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165
What this trial is testing

Ribociclib and Bicalutamide in AR+ TNBC

Who this might be right for
Triple Negative Breast Cancer
Kari Wisinski 37
Large-scale testing (Phase 3)Study completedNCT01216111
What this trial is testing

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Who this might be right for
Triple Negative Breast Cancer
Fudan University 647
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Very early researchStudy completedNCT03599453
What this trial is testing

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple -Negative Breast CancerEstrogen Receptor NegativeHER2/Neu Negative+2 more
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00608972
What this trial is testing

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 31
Testing effectiveness (Phase 2)Ended earlyNCT00817531
What this trial is testing

Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Baylor Breast Care Center 22
Early research (Phase 1)Study completedNCT01155453
What this trial is testing

Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Who this might be right for
Advanced and Selected Solid Tumors
Novartis Pharmaceuticals 113
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Load More Results